Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Category > Report Information Email a colleague | Printer format

In Pursuit of the Paperless Clinical Trial: A look at EDC and CTMS (Strategy Focus)

Datamonitor
July 2, 2008
52 Pages - Pub ID: DFMN1819301
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports


Introduction

The cost of developing a drug is reaching astronomical levels, and the life science industry is looking to cut costs wherever possible. Therefore, company executives are turning their attention to improving inefficiencies during the most expensive phase of drug development clinical trials. This report will analyze software solutions developed to streamline the clinical research process.

Scope
  • Identifies the key forces driving the adoption of eClinical technology solutions
  • Analyzes the crucial issues that will impede the uptake of clinical research tools
  • Discusses the key functionalities needed for a complete eClinical solution
  • Offers insight into how IT vendors can improve their products and evaluates key vendors in the market
Highlights

With costs skyrocketing, companies are turning to computerized systems and IT solutions to increase productivity and maximize the efficiency of clinical trials. The adoption of EDC and CTMS solutions will be integral in enhancing and transforming the data collection and management aspects of a trial.

To fully leverage the benefits of these technologies, eClinical solutions must be built on an interoperable framework that will enable life science companies to run clinical trials in a more efficient manner since many redundancies which currently exist in the point solutions will be eliminated.

Until all stakeholders in the clinical trial process are educated on the true features and benefits of modern clinical technologies and are willing to make the necessary mental and cultural switch, adoption of eClinical solutions will remain sluggish. Vendors should take this opportunity to partner with companies to enhance the research process.

Reasons to Purchase
  • Validate your market messaging and positioning in the life science industry
  • Identify strategies that will increase adoption of eClinical technologies
  • Understand the technology trends that are shaping the future of clinical trials


Related Reports:
Prostate Cancer Drug Discoveries: What the Future Holds
BI for Drug Development: Oracle Introduces Clinical Development Analytics
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis
Asia Pacific Pharma Sector Analysis
China Pharma Outsourcing Annual Review 2009
Competitor Analysis: TGF-R Agonists and Antagonists
Competitor Analysis: FGF-R Agonists and Antagonists
Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 2